ConductScience.org, home

Paper40176397

Metabolic Consequences of Rheumatoid Arthritis.

Barry S and 2 others. Arthritis Care Res (Hoboken), 2025. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. Metabolic Consequences of Rheumatoid Arthritis. Papers, record 40176397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40176397

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Metabolic Consequences of Rheumatoid Arthritis.
PubMed
Journal
Arthritis Care Res (Hoboken)
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
3.86, provisional
iCite
Revised in PubMed
2026-06-19
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Barry SSteviehttps://orcid.org/0009-0007-4591-1085
2Sheng EEmily
3Baker JFJoshua F

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Arthritis, RheumatoidMajor topic
Humans
Insulin Resistance
Metabolic Syndrome
Body Composition
Blood Pressure

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
I01 RX003644RRD VAUnited StatesI01RX003644PubMed and NIHNIH RePORTER
I01 RX004770RRD VAUnited StatesI01RX004770PubMed and NIHNIH RePORTER
R01 AR083584NIAMS NIH HHSUnited StatesR01AR083584PubMed and NIHNIH RePORTER
R01-AR083584NIAMS NIH HHSUnited StatesR01AR083584PubMed and NIHNIH RePORTER

Download CSV of grants

References85

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127338263Body mass index distribution in rheumatoid arthritis: a collaborative analysis from three large German rheumatoid arthritis databases.Arthritis Res Ther2016https://conductscience.org/library/papers/27338263PubMed
238216757Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician.Nat Rev Rheumatol2024https://conductscience.org/library/papers/38216757PubMed
323950188Disease factors in early rheumatoid arthritis are associated with differential risks for cardiovascular events and mortality depending on age at onset: a 10-year observational cohort study.J Rheumatol2013https://conductscience.org/library/papers/23950188PubMed
428845751Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.N Engl J Med2017https://conductscience.org/library/papers/28845751PubMed
527079757Effects of tofacitinib and other DMARDs on lipid profiles in rheumatoid arthritis: implications for the rheumatologist.Semin Arthritis Rheum2016https://conductscience.org/library/papers/27079757PubMed
629544870Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes.J Am Coll Cardiol2018https://conductscience.org/library/papers/29544870PubMed
733666156
Benefits of anakinra versus TNF inhibitors in rheumatoid arthritis and type 2 diabetes: long-term findings from participants furtherly followed-up in the TRACK study, a multicentre, open-label, randomised, controlled trial.
Clin Exp Rheumatol2021https://conductscience.org/library/papers/33666156PubMed
825303044Lipid profile changes in patients with chronic inflammatory arthritis treated with biologic agents and tofacitinib in randomized clinical trials: a systematic review and meta-analysis.Arthritis Rheumatol2015https://conductscience.org/library/papers/25303044PubMed
931513665Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial.PLoS Med2019https://conductscience.org/library/papers/31513665PubMed
1035366608Lipoprotein oxidation may underlie the paradoxical association of low cholesterol with coronary atherosclerotic risk in rheumatoid arthritis.J Autoimmun2022https://conductscience.org/library/papers/35366608PubMed
1133771189Impact of disease activity on impaired glucose metabolism in patients with rheumatoid arthritis.Arthritis Res Ther2021https://conductscience.org/library/papers/33771189PubMed
1237453736Relationship Between Paraoxonase-1 Genotype and Activity, and Major Adverse Cardiovascular Events and Malignancies in Patients With Rheumatoid Arthritis Receiving Tofacitinib.J Rheumatol2023https://conductscience.org/library/papers/37453736PubMed
1331721697Methotrexate and Vasculoprotection: Mechanistic Insights and Potential Therapeutic Applications in Old Age.Curr Pharm Des2019https://conductscience.org/library/papers/31721697PubMed
1436450449Reducing cardiovascular risk with immunomodulators: a randomised active comparator trial among patients with rheumatoid arthritis.Ann Rheum Dis2023https://conductscience.org/library/papers/36450449PubMed
1520589684Abdominal adiposity in rheumatoid arthritis: association with cardiometabolic risk factors and disease characteristics.Arthritis Rheum2010https://conductscience.org/library/papers/20589684PubMed
1633397733Disease activity, cytokines, chemokines and the risk of incident diabetes in rheumatoid arthritis.Ann Rheum Dis2021https://conductscience.org/library/papers/33397733PubMed
1727697765EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update.Ann Rheum Dis2017https://conductscience.org/library/papers/27697765PubMed
1835021057Inflammation in obesity, diabetes, and related disorders.Immunity2022https://conductscience.org/library/papers/35021057PubMed
1925535750Diabetes mellitus risk factors in rheumatoid arthritis: a systematic review and meta-analysis.Clin Exp Rheumatol2015https://conductscience.org/library/papers/25535750PubMed
2032907617Interleukin-6 receptor blockade or TNFα inhibition for reducing glycaemia in patients with RA and diabetes: post hoc analyses of three randomised, controlled trials.Arthritis Res Ther2020https://conductscience.org/library/papers/32907617PubMed

See all 85 referencesDownload CSV of references

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
42953051Gut microbiota and intestinal permeability in rheumatoid arthritis: therapeutic implications and future directions.Front Immunol2026https://conductscience.org/library/papers/42953051PubMed
42688426Factors associated with concurrent cardiovascular disease in patients with rheumatoid arthritis and development of machine learning models for comorbidity identification.Front Cardiovasc Med2026https://conductscience.org/library/papers/42688426PubMed
42609198Bibliometric analysis of research on sarcopenia in rheumatoid arthritis: 1997-2025.Front Med (Lausanne)2026https://conductscience.org/library/papers/42609198PubMed
42602085Neutrophil percentage-to-albumin ratio is associated with low muscle mass risk in rheumatoid arthritis: evidence from a hospital-based cohort and NHANES validation.Front Immunol2026https://conductscience.org/library/papers/42602085PubMed
42589137Lipid Immunometabolism in Autoimmune Rheumatic Diseases: Mechanistic Links Between Chronic Inflammation, Lipoprotein Dysfunction and Cardiovascular Risk.Biology (Basel)2026https://conductscience.org/library/papers/42589137PubMed
42558807Manual dexterity and plaque accumulation in patients with rheumatoid arthritis.Front Oral Health2026https://conductscience.org/library/papers/42558807PubMed
42470822Recent advances in methotrexate pharmacology and potential therapeutic uses in age-related cardiometabolic and neurodegenerative diseases.Pharmacol Rev2026https://conductscience.org/library/papers/42470822PubMed
42072621The N6-Methyladenosine RNA Demethylase AlkB Homolog 5 (ALKBH5) in Metabolic Diseases: Molecular Mechanisms and Pharmacological Implications-A Review.Biomolecules2026https://conductscience.org/library/papers/42072621PubMed
41754190Nutritional Risk in Older Adults with Rheumatoid Arthritis: Sex-Specific Patterns and Clinical Implications of the Prognostic Nutritional Index.Nutrients2026https://conductscience.org/library/papers/41754190PubMed
41459480Integrated analysis of the relationship between metabolic pathways and immune infiltration in rheumatoid arthritis.Front Immunol2025https://conductscience.org/library/papers/41459480PubMed
41007860A Potential Role of Adropin in Inflammatory Rheumatic Diseases-What Do We Know So Far?Biomedicines2025https://conductscience.org/library/papers/41007860PubMed
40802417Polypharmacy and drug interactions in the management of rheumatoid arthritis.Rev Assoc Med Bras (1992)2025https://conductscience.org/library/papers/40802417PubMed
40565171Endocannabinoid Tone and Oxylipins in Rheumatoid Arthritis and Osteoarthritis-A Novel Target for the Treatment of Pain and Inflammation?Int J Mol Sci2025https://conductscience.org/library/papers/40565171PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40176397

GET https://conductscience.org/api/papers/v1/40176397/references?page=2